Ledger.Open graph →
SEC Form D · filed March 1, 2018

Quentis Therapeutics, Inc

Offering
$47.9M
Sold
$19.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Carlo Rizzuto · New York, NYExec · DirectorMichael Aberman · New York, NYExec · DirectorMichael Foley · New York, NYDirectorMichael Aberman · New York, NYExec · DirectorMichael Foley · New York, NYDirectorAmy Schulman · Waltham, MADirectorCarlo Rizzuto · New York, NYExec · DirectorAmy Schulman · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗